EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Farnesoid X Receptor Agonist GW4064 Protects Lipopolysaccharide-Induced Intestinal Epithelial Barrier Function and Colorectal Tumorigenesis Signaling through the αKlotho/βKlotho/FGFs Pathways in Mice

Hsuan-Miao Liu iD, Zi-Yu Chang iD, Ching-Wei Yang, Hen-Hong Chang iD, Tzung-Yan Lee iD

International Journal of Molecular Sciences · 29.11.2023 · 24 (23) · 16932

DOI: 10.3390/ijms242316932 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.11.2023. Verfasst von Hsuan-Miao Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Traditional Chinese Medicine, School of Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan. Hauptthemen laut MEDLINE: Intestinal Diseases, Colorectal Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Linkou Chang Gung Memorial Hospital, National Science and Technology Council, Chang Gung Memorial Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The farnesoid X receptor (FXR)/βKlotho/fibroblast growth factors (FGFs) pathway is crucial for maintaining the intestinal barrier and preventing colorectal cancer (CRC). We used an FXR agonist, GW4064, and FXR-knockout (FXR-KO) mice to investigate the role of FXR/Klothos/FGFs pathways in lipopolysaccharide (LPS)-induced intestinal barrier dysfunction and colon carcinogenesis. The results showed that upregulation of FXR in enterocytes effectively ameliorated intestinal tight-junction markers (claudin1 and zonula occludens-1), inflammation, and bile acid levels, thereby protecting mice from intestinal barrier dysfunction and colon carcinogenesis. GW4064 treatment increased FXR, αKlotho, βKlotho, FGF19, FGF21, and FGF23 in wild-type mice exposed to LPS, while FXR-KO mice had decreased levels. FXR-KO mice exhibited elevated colon cancer markers (β-catenin, LGR5, CD44, CD34, and cyclin D1) under LPS, underscoring the pivotal role of FXR in inhibiting the development of colon tumorigenesis. The varying gut microbiota responses in FXR-KO mice versus wild-type mice post LPS exposure emphasize the pivotal role of FXR in preserving intestinal microbial health, involving Bacteroides thetaiotaomicron, Bacteroides acidifaciens, and Helicobacter hepaticus. Our study validates the effectiveness of GW4064 in alleviating LPS-induced disruptions to the intestinal barrier and colon carcinogenesis, emphasizing the importance of the FXR/αKlotho/βKlotho/FGFs pathway and the interplay between bile acids and gut microbiota.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intestinal DiseasesColorectal NeoplasmsMiceAnimalsLipopolysaccharidesReceptors, Cytoplasmic and NuclearCell Transformation, NeoplasticBile Acids and SaltsFibroblast Growth FactorsMice, Inbred C57BLIsoxazoles

Stichwörter der Autor:innen

Klothocolon cancerfarnesoid X receptorfibroblast growth factorgut microbiotaintestinal epithelial barrier

Substanzen

LipopolysaccharidesReceptors, Cytoplasmic and NuclearBile Acids and SaltsFibroblast Growth FactorsGW 4064Isoxazoles

Autor:innen und Institutionen

  • Graduate Institute of Traditional Chinese Medicine, School of Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
  • Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital, Keelung 20401, Taiwan.
  • Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
  • Division of Internal and Pediatric Chinese Medicine, Center for Traditional Chinese Medicine, Chang Gung Memorial Hospital, Linkou 333423, Taiwan.
  • Graduate Institute of Integrated Medicine, China Medical University, Taichung 40402, Taiwan.

ORCID-Profile: Hsuan-Miao Liu, Zi-Yu Chang, Hen-Hong Chang, Tzung-Yan Lee

Förderung

  • Linkou Chang Gung Memorial Hospital
  • National Science and Technology Council
  • Chang Gung Memorial Hospital

Zitieren

APA

Liu, H. M., Chang, Z. Y., Yang, C. W., Chang, H. H., & Lee, T. Y. (2023). Farnesoid X Receptor Agonist GW4064 Protects Lipopolysaccharide-Induced Intestinal Epithelial Barrier Function and Colorectal Tumorigenesis Signaling through the αKlotho/βKlotho/FGFs Pathways in Mice. International Journal of Molecular Sciences, 24(23), 16932. https://doi.org/10.3390/ijms242316932

Vancouver

Liu HM, Chang ZY, Yang CW, Chang HH, Lee TY. Farnesoid X Receptor Agonist GW4064 Protects Lipopolysaccharide-Induced Intestinal Epithelial Barrier Function and Colorectal Tumorigenesis Signaling through the αKlotho/βKlotho/FGFs Pathways in Mice. International Journal of Molecular Sciences. 2023;24(23):16932. doi:10.3390/ijms242316932

BibTeX
@article{Liu2023,
  author = {Liu, Hsuan-Miao and Chang, Zi-Yu and Yang, Ching-Wei and Chang, Hen-Hong and Lee, Tzung-Yan},
  title = {Farnesoid X Receptor Agonist GW4064 Protects Lipopolysaccharide-Induced Intestinal Epithelial Barrier Function and Colorectal Tumorigenesis Signaling through the αKlotho/βKlotho/FGFs Pathways in Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {23},
  pages = {16932},
  doi = {10.3390/ijms242316932}
}
Kostenlos starten →